Bill Title: Enacts the pharmaceutical cost transparency act of 2015 requiring prescription drug manufacturers to file a report disclosing certain financial information pertaining to prescription drugs which have a wholesale acquisition cost of $10,000 or more annually or per course of treatment.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2016-01-06 - referred to health [A08265 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	1969-12-31	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New York A08265

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New York A08265 currently on file.

Social Comments on NY A08265